These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8384748)
1. Phenotypic and functional characterization of mouse attenuated and virulent variants of foot-and-mouth disease virus type O1 Campos. Jensen MJ; Moore DM Virology; 1993 Apr; 193(2):604-13. PubMed ID: 8384748 [TBL] [Abstract][Full Text] [Related]
2. Role of arginine-56 within the structural protein VP3 of foot-and-mouth disease virus (FMDV) O1 Campos in virus virulence. Borca MV; Pacheco JM; Holinka LG; Carrillo C; Hartwig E; Garriga D; Kramer E; Rodriguez L; Piccone ME Virology; 2012 Jan; 422(1):37-45. PubMed ID: 22036313 [TBL] [Abstract][Full Text] [Related]
3. [Nucleotide sequence of the RNA polymerase gene attenuated by a variant of foot-and-mouth disease virus and its comparison with the virulence of related variants of subtype A22]. Lomakina NF; Rybakov SS Mol Gen Mikrobiol Virusol; 1996; (1):35-40. PubMed ID: 8786750 [TBL] [Abstract][Full Text] [Related]
4. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease. Dunn CS; Samuel AR; Pullen LA; Anderson J Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571 [TBL] [Abstract][Full Text] [Related]
5. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants. Ni H; Barrett AD Virology; 1998 Feb; 241(1):30-6. PubMed ID: 9454714 [TBL] [Abstract][Full Text] [Related]
6. Detection and characterization of functional T-cell epitopes on the structural proteins VP2, VP3, and VP4 of foot and mouth disease virus O1 campos. Pérez Filgueira M; Wigdorovitz A; Romera A; Zamorano P; Borca MV; Sadir AM Virology; 2000 Jun; 271(2):234-9. PubMed ID: 10860876 [TBL] [Abstract][Full Text] [Related]
7. Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. Neff S; Sá-Carvalho D; Rieder E; Mason PW; Blystone SD; Brown EJ; Baxt B J Virol; 1998 May; 72(5):3587-94. PubMed ID: 9557639 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus. Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367 [TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of recombinants between attenuated and virulent aphthovirus strains. Giraudo AT; Sagedahl A; Bergmann IE; La Torre JL; Scodeller EA J Virol; 1987 Feb; 61(2):419-25. PubMed ID: 3027372 [TBL] [Abstract][Full Text] [Related]
10. Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A. O'Donnell VK; Pacheco JM; Henry TM; Mason PW Virology; 2001 Aug; 287(1):151-62. PubMed ID: 11504550 [TBL] [Abstract][Full Text] [Related]
11. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Mayr GA; Chinsangaram J; Grubman MJ Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121 [TBL] [Abstract][Full Text] [Related]
12. Rapid selection in modified BHK-21 cells of a foot-and-mouth disease virus variant showing alterations in cell tropism. Escarmís C; Carrillo EC; Ferrer M; Arriaza JF; Lopez N; Tami C; Verdaguer N; Domingo E; Franze-Fernández MT J Virol; 1998 Dec; 72(12):10171-9. PubMed ID: 9811758 [TBL] [Abstract][Full Text] [Related]
13. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146 [TBL] [Abstract][Full Text] [Related]
14. Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. Rieder E; Bunch T; Brown F; Mason PW J Virol; 1993 Sep; 67(9):5139-45. PubMed ID: 8394441 [TBL] [Abstract][Full Text] [Related]
15. A second RGD motif in the 1D capsid protein of a SAT1 type foot-and-mouth disease virus field isolate is not essential for attachment to target cells. Storey P; Theron J; Maree FF; O'Neill HG Virus Res; 2007 Mar; 124(1-2):184-92. PubMed ID: 17161881 [TBL] [Abstract][Full Text] [Related]
17. Functional characterization of the HveA homolog specified by African green monkey kidney cells with a herpes simplex virus expressing the green fluorescence protein. Foster TP; Chouljenko VN; Kousoulas KG Virology; 1999 Jun; 258(2):365-74. PubMed ID: 10366573 [TBL] [Abstract][Full Text] [Related]
18. Genome analysis and development of infectious cDNA clone of a virulence-attenuated strain of foot-and-mouth disease virus type Asia 1 from China. Xin A; Li H; Li L; Liao D; Yang Y; Zhang N; Chen B Vet Microbiol; 2009 Sep; 138(3-4):273-80. PubMed ID: 19410387 [TBL] [Abstract][Full Text] [Related]
19. The potential of recombination for the production of foot-and-mouth disease virus vaccine strains. McCahon D; King AM; Slade WR; Skinner HH; Haresnape J Dev Biol Stand; 1980; 46():223-30. PubMed ID: 6244999 [TBL] [Abstract][Full Text] [Related]
20. Antigenic and genetic analyses of foot-and-mouth disease virus type A isolates for selection of candidate vaccine strain reveals emergence of a variant virus that is responsible for most recent outbreaks in India. Jangra RK; Tosh C; Sanyal A; Hemadri D; Bandyopadhyay SK Virus Res; 2005 Sep; 112(1-2):52-9. PubMed ID: 16022900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]